Merck&#39;s Missing Vioxx Study
519933
NEW YORK - Should Merck have conducted a bigger trial to test the safety of its arthritis drug Vioxx? Merck (nyse: MRK - news - people ) pulled Vioxx from the market two weeks ago, but questions about the
133867
The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises
19693
An arthritis drug should have been taken off the market years before it was finally withdrawn, say researchers. Manufacturer Merck withdrew Vioxx in September after evidence linking it to heart problems.
390243
People taking Vioxx may feel betrayed now that the popular painkiller and arthritis medicine has been pulled from the market. Merck, the manufacturer of the drug, and the US Food and Drug Administration knew
147266
BOSTON (CBS.MW) -- Merck &amp; Co. said late Tuesday that it is establishing a committee to review its handling of the controversial withdrawal of its popular painkiller Vioxx from the market.
485027
Drug maker Merck &amp; Co. reported Tuesday that its board appointed a special committee to review the company&#39;s actions before withdrawing blockbuster arthritis drug Vioxx from the market Sept.
33474
On September 30, 2004, Merck &amp; Co. announced the immediate recall of one of its COX-2 inhibitors, the anti-inflammatory drug VIOXXÂ®, because, in Merck&#39;s own words, a study it had been conducting showed that:
219397
NEW YORK (CBS.MW) -- Merck (MRK) is out with a statement that &quot;strongly disagrees&quot; with the findings of a new study that raised questions about the safety of its Vioxx arthritis drug.
428395
Merck & Co Inc. is evaluating why its withdrawn painkiller Vioxx raises the chance of heart attack and stroke, but it has not found a mechanism of action, a company official said on Monday.
506626
Merck pulled Vioxx from the market on September 30th, saying it was acting in the best interest of patients. But internal documents reportedly show the company knew as far back as 2000 that
569961
By Rosie Murray-West, City Correspondent (Filed: 01/10/2004). US pharmaceutical giant Merck lost about a quarter of its value yesterday after it pulled arthritis drug Vioxx owing to concerns over heart attacks as a side-effect.
333725
Merck &amp; Co. (MRK.N: Quote, Profile, Research) said on Thursday withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
557443
Top executives at pharmaceutical giant Merck & Co. Inc. decided in May 2000 against developing a study to test directly whether its Vioxx painkiller drug might pose a heart risk, The New York Times reported on Saturday.
365940
Previously undisclosed Merck documents show that it was poised to begin a study of Vioxx in 2002 but abruptly dropped the project just before it was set to start.
80277
The arthritis drug Vioxx, used by  millions of people around the world, is being pulled off the  market after a study confirmed long-standing concerns that it  raises the risk of heart attack and stroke, the manufacturer,  Merck & Co. MRK.N, said on Thursday.
497670
Oct. 11 issue - Last week Merck pulled its blockbuster arthritis-and-pain-relief drug Vioxx from the market. This week the 1.27 million Americans who were taking it are wondering what to do.
51395
Merck &amp; Co. withdrew the popular drug Vioxx from the market in September, after data from a clinical trial supported claims the medication was associated with an increased risk of heart attack and stroke.